Meet China’s New Innovators: UStar Biotech Makes Molecular Testing Available Under A Tree
This article was originally published in PharmAsia News
Executive Summary
Low costs and mass manufacturing are enabling Chinese innovators to expand access to onsite diagnostics in the developing world, aided by organizations such as the Bill and Melinda Gates Foundation.